Since then, the effect of the zonulin pathway on the regulation of intestinal permeability has been supported by phase 2 clinical studies demonstrating the beneficial effect of the zonulin antagonist larazotide acetate (AT-1001) in patients with celiac disease [10]. The gene discussed is HP; the disease is celiac disease.